Showing results (121-130 of 400) with videos related to
Sort By:
Pageof 40
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subsetA M Kruisbeek, S Bridges, J Carmen, et al.Clinical Pharmacology and Therapeutics|November 3, 2016
Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple MyelomaJ P Laubach, C E Paba Prada, P G Richardson, et al.Immunological Reviews|August 22, 2001
Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studiesW J Murphy, C Y Koh, A Raziuddin, et al.International Immunology|December 1, 1996
Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in miceA Raziuddin, D L Longo, L Mason, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
A role for cytokines in antigen presentation: IL-1 and IL-4 induce accessory functions of antigen-presenting cellsF B Aiello, D L Longo, R Overton, et al.The Journal of Experimental Medicine|February 1, 1990
CD8 is required during positive selection of CD4-/CD8+ T cellsJ C Zúñiga-Pflücker, L A Jones, D L Longo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Synergistic effects of retinoic acid and 8-chloro-adenosine 3',5'-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: involvement of mitochondriaR K Srivastava, A R Srivastava, Y S Cho-Chung, et al.Oncogene|April 20, 1999
Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cellsR K Srivastava, A R Srivastava, Y S Cho-Chung, et al.International Journal of Cancer|March 30, 2000
Synergistic anti-tumoral effect of paclitaxel (Taxol)+AS101 in a murine model of B16 melanoma: association with ras-dependent signal-transduction pathwaysY Kalechman, D L Longo, R Catane, et al.Brain, Behavior, and Immunity|December 1, 1992
Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphomaW J Murphy, S K Durum, M Anver, et al.Pageof 40